Da-Yong Lu Selected Research

Razoxane

11/2010	Cell biological manifestations of bisdioxopiperazines treatment of human tumor cell lines in culture.
9/2010	Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
1/2010	Anticancer activities and mechanisms of bisdioxopiperazine compounds probimane and MST-16.
7/2006	Medicinal chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines.
12/2004	Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Da-Yong Lu Research Topics

Disease

13	Neoplasms (Cancer) 09/2021 - 12/2004
8	Neoplasm Metastasis (Metastasis) 09/2021 - 12/2004
4	Lewis Lung Carcinoma 01/2013 - 07/2006
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 01/2014
2	Gallstones (Gallstone) 06/2022 - 07/2020
1	COVID-19 01/2022
1	HIV Infections (HIV Infection) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Diabetes Mellitus 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Heart Failure 01/2017
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2017
1	Insulin Resistance 01/2017
1	Obesity 01/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Infections 01/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Ascites 01/2013
1	Hearing Loss (Hearing Impairment) 12/2012
1	Virus Diseases (Viral Diseases) 01/2007

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 09/2021 - 12/2004
5	RazoxaneIBA 11/2010 - 12/2004
4	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2013 - 01/2010
4	probimane (AT 2153)IBA 01/2013 - 12/2004
4	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 07/2006
3	1,2-bis(3,5-dioxopiperazin-1-yl)ethaneIBA 09/2010 - 07/2006
2	AIDS VaccinesIBA 01/2018 - 01/2016
2	Drug CombinationsIBA 01/2017 - 01/2017
2	SolutionsIBA 01/2016 - 09/2010
2	Sialic AcidsIBA 01/2013 - 07/2012
2	Antidepressive Agents (Antidepressants)IBA 12/2012 - 01/2008
2	sobuzoxaneIBA 11/2010 - 07/2006
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 09/2010 - 01/2010
2	Fibrinogen (Factor I)FDA Link 09/2010 - 01/2010
1	PowdersIBA 06/2022
1	CholesterolIBA 06/2022
1	Calcium Carbonate (Limestone)FDA Link 07/2020
1	Antiviral Agents (Antivirals)IBA 01/2018
1	VaccinesIBA 01/2018
1	Plant ExtractsIBA 01/2018
1	Anthocyanins (Anthocyanin)IBA 01/2017
1	AndrogensIBA 01/2017
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Testosterone (Sustanon)FDA Link 01/2017
1	CytokinesIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	ungeremine (AT 1840)IBA 01/2013
1	Cortisone FDA Link 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Chelating AgentsIBA 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2013
1	harringtoninIBA 01/2013
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2013
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2013
1	Vincristine (Oncovin)FDA LinkGeneric 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2012
1	N-glycolylneuraminic acidIBA 07/2012
1	Matrix Metalloproteinase InhibitorsIBA 07/2012
1	AntigensIBA 07/2012
1	matrigelIBA 11/2010
1	GTP Phosphohydrolases (GTPases)IBA 11/2010
1	Dexrazoxane (Zinecard)FDA LinkGeneric 11/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 09/2010
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2004
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2004

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2008
3	Drug Therapy (Chemotherapy) 09/2021 - 01/2018
1	Cholecystectomy 06/2022
1	Highly Active Antiretroviral Therapy (HAART) 01/2018
1	Antineoplastic Combined Chemotherapy Protocols 01/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017
1	Biological Therapy 01/2007